Refine your search

Your search returned 15 results.

Sort
Results
Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA risk assessments ; 9Language: Engels
Publication details: Lisbon EMCDDA 2011
Availability: Items available for reference: VAD: Not for loan (1).
Report on the risk assessment of MT-45 in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 17Language: Engels
Publication details: Lisbon EMCDDA 2015
Availability: Items available for reference: VAD: Not for loan (1).
Report on the risk assessment of 4,4′-DMAR in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 16Language: Engels
Publication details: Lisbon EMCDDA 2015
Availability: Items available for reference: VAD: Not for loan (1).
Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA risk assessments ; 7Language: Engels
Publication details: Lisboa EMCDDA 2004
Availability: Items available for reference: VAD: Not for loan (1).
Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA risk assessments ; 6Language: Engels
Publication details: Lisboa EMCDDA 2004
Availability: Items available for reference: VAD: Not for loan (1).
ADB-CHMINACA : Report on the risk assessment of N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 22Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
CUMYL-4CN-BINACA : report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)1H-indazole-3-carboxamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 22Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Carfentanyl: report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 28Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
4F-iBF : Report on the risk assessment of N-(4fluorophenyl)-2-methyl-N-[1-(2-phenylethyl) piperidin-4-yl]propanamide in the framework of the Council Decision on new psychoactive substance [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 26Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
5F-MDMB-PINACA : report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3carbonyl]amino}-3,3-dimethylbutanoate in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 25Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
AB-CHMINACA : report on the risk assessment of N-(1amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 24Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
THF-F : report on the risk assessment of N-phenylN-[1-(2-phenylethyl)piperidin-4yl]oxolane-2-carboxamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 27Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Methoxyacetylfentanyl : report on the risk assessment of 2-methoxyN-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] acetamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 30Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Cyclopropylfentanyl : report on the risk assessment of N-phenylN-[1-(2-phenylethyl)piperidin-4-yl] cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 30Language: Engels
Publication details: Lisbon EMCDDA 2018
Availability: Items available for reference: VAD: Not for loan (1).
Isotonitazene Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole-1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 31Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Pages